Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Molecular Cancer Therapeutics|January 28, 2010
Human mutations that confer paclitaxel resistanceShanghua Yin, Rajat Bhattacharya, Fernando CabralMolecular Cancer Therapeutics|October 17, 2007
Amino acid substitutions at proline 220 of beta-tubulin confer resistance to paclitaxel and colcemidShanghua Yin, Fernando Cabral, Sudha VeeraraghavanCytoskeleton (Hoboken, N.J.)|October 25, 2013
Paclitaxel resistance by random mutagenesis of α-tubulinShanghua Yin, Changqing Zeng, Malathi Hari, et al.Cytoskeleton (Hoboken, N.J.)|February 11, 2011
Megakaryocyte lineage-specific class VI β-tubulin suppresses microtubule dynamics, fragments microtubules, and blocks cell divisionHailing Yang, Anutosh Ganguly, Shanghua Yin, et al.Pharmaceutical Research|June 7, 2012
Random mutagenesis of β-tubulin defines a set of dispersed mutations that confer paclitaxel resistanceShanghua Yin, Changqing Zeng, Malathi Hari, et al.Biochemistry|January 4, 2006
Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanismsYaqing Wang, Shanghua Yin, Kristie Blade, et al.Pageof 1